EUVIMEDEUVIMED entdecken
Open Access

Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms

Shafinaz Eisha iD, Amanda J Morris iD, Isaac Martin, Yvonne C W Yau, Hartmut Grasemann, Valerie Waters iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00336-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Shafinaz Eisha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Arginine, Cystic Fibrosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) airways are L-arginine deficient which may affect susceptibility to infection with certain pathogens. The potential impact of L-arginine supplementation on Pseudomonas aeruginosa , a common CF airway pathogen, is unclear. This study investigated the effects of L-arginine on P. aeruginosa biofilm cultures, using the laboratory strain PAO1 and multi-drug resistant CF clinical isolates. P. aeruginosa biofilms were grown in a chambered cover-glass slide model for 24 h, then exposed to either L-arginine alone or combined with tobramycin for an additional 24 h. Biofilms were visualized using confocal microscopy, and viable cells were measured via plating for colony-forming units. Increasing concentrations of L-arginine in bacterial culture medium reduced the biovolume of P. aeruginosa in a dose-dependent manner. Notably, L-arginine concentrations within the physiological range (50 mM and 100 mM) in combination with tobramycin promoted biofilm growth, while higher concentrations (600 mM and 1200 mM) inhibited growth. These findings demonstrate the potential of L-arginine as an adjuvant therapy to inhaled tobramycin in treating P. aeruginosa infections in people with CF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsPseudomonas aeruginosaArginineCystic FibrosisTobramycinAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsPseudomonas InfectionsDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

L-argininePseudomonas aeruginosabiofilmcystic fibrosistobramycin

Substanzen

ArginineTobramycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Translational Medicine, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Division of Respiratory Medicine, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Division of Microbiology, Department of Pediatric Laboratory Medicine, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

ORCID-Profile: Shafinaz Eisha, Amanda J Morris, Valerie Waters

Zitieren

APA

Eisha, S., Morris, A. J., Martin, I., Yau, Y. C. W., Grasemann, H., & Waters, V. (2024). Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00336-24

Vancouver

Eisha S, Morris AJ, Martin I, Yau YCW, Grasemann H, Waters V. Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00336-24

BibTeX
@article{Eisha2024,
  author = {Eisha, Shafinaz and Morris, Amanda J and Martin, Isaac and Yau, Yvonne C W and Grasemann, Hartmut and Waters, Valerie},
  title = {Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00336-24}
}
Kostenlos starten →